|
Meet brain and eye researcher Dr. Pierre Mattar
April 25, 2022
-
Dr. Pierre Mattar is doing the groundwork needed to develop treatments for vision loss
|
|
First made-in-Canada CAR-T therapy gives lymphoma patient a third chance
January 10, 2022
-
Faced with the return of his lymphoma for the third time in ten years, Owen Snider was running out of options. But there was new hope when he was accepted into a made-in-Canada CAR-T therapy clinical trial.
|
|
Medicine’s future: living drugs
November 19, 2021
-
The Ottawa Hospital’s Biotherapeutics Manufacturing Centre harnessing the life-saving power of biological therapies
|
Show more news stories
|
|
$2.4 M grant to help researchers develop gene and cell therapies for a leading cause of blindness
September 15, 2021
-
A team led by Dr. Catherine Tsilfidis has received $2.4 M from the Ontario Research Fund to develop treatments for retinal diseases, a leading cause of blindness.
|
|
Biomanufacturing partnership boosts Canada’s life-saving treatment and vaccine capacity
September 13, 2021
-
As Canada seeks to rebuild its biomanufacturing sector and support made-in-Canada solutions to global health challenges, The Ottawa Hospital, the University of Alberta and BioCanRx have collaborated to create Canada’s first full-service, end-to-end b
|
|
Biotherapeutics: the future of medicine
May 25, 2021
-
World-class biotherapeutics facility at The Ottawa Hospital uses cells, genes and viruses to create unique life-saving treatments
|
|
Experts on call: Stem cells, gene therapy and biotherapeutics
April 22, 2021
-
Could biotherapeutics be the key to the next wave of medical breakthroughs? Join this lively discussion to learn how researchers at The Ottawa Hospital are using biological materials like cells, genes and viruses to heal the body and fight disease.
|
|
Grateful COVID-19 patient gives back by participating in research
April 13, 2021
-
Sharon Charlebois doesn’t remember much about the 25 days she spent at The Ottawa Hospital fighting a severe case of COVID-19 in January 2021. Now that she’s recovering at home with her husband, some memories come back to her in flashes.
|
|
The rise of point-of-care cell manufacturing
March 12, 2021
-
Decentralized approach represents a paradigm shift in the way Canada studies, commercializes and delivers stem cell treatments for serious diseases
|
|
Cancer team awarded $5M for cell-based immunotherapy research
March 3, 2021
-
Researchers at The Ottawa Hospital and the University of Ottawa are partnering with colleagues across the country to expand Canada’s capacity to develop new cell-based immunotherapies for cancer with a $5.2 million grant from the Canada Foundation fo
|
|
One small step for blood cancer patients, one giant step for Canadian cancer patients of all stripes
February 25, 2021
-
The Canadian-Led Immunotherapies in Cancer (CLIC) research program is building Canada’s capacity for innovation in CAR-T therapy, with support from BioCanRx, The Ottawa Hospital, BC Cancer and the Ontario Institute for Cancer Research
|
|
Experimental stem cell therapy a potential weapon against COVID-19
February 1, 2021
-
Drs. Duncan Stewart, Shane English, Dean Fergusson and colleagues have launched a clinical trial to test MSCs in people with severe COVID-19.
|
|
$1M investment fuels development of new therapies for Duchenne muscular dystrophy
February 1, 2021
-
Parent Project Muscular Dystrophy has invested $1M in Satellos Bioscience, a startup company founded by Dr. Michael Rudnicki.
|
|
$1M grant to support manufacturing of COVID-19 treatments and vaccines at The Ottawa Hospital and uOttawa
November 6, 2020
-
Researchers from The Ottawa Hospital and the University of Ottawa have been awarded $1,050,000 from the Canada Foundation for Innovation to support facilities for manufacturing innovative treatments and vaccines for COVID-19.
|
|
The Ottawa Hospital and uOttawa launch new cancer immunotherapy research projects with funding from BioCanRx
September 22, 2020
-
BioCanRx, Canada’s Immunotherapy Network, today announced funding of $10M for 14 cancer immunotherapy research projects and eight core and biomanufacturing facilities across the country. Researchers at The Ottawa Hospital (TOH) and the University of
|
|
Experimental Stem Cell Therapy a Potential Weapon in COVID-19 Fight
May 28, 2020
-
Ottawa-based researchers pivot at lightning speed to launch study on treating related respiratory failure
|
|
COVID-19 research on cell therapy, drug screening and marginalized populations funded through Ontario’s Rapid Research Fund
May 21, 2020
-
Researchers from The Ottawa Hospital, affiliated with the University of Ottawa, have been awarded almost $2 million from Ontario’s COVID-19 Rapid Research Fund for three research projects that could help in the fight against the virus. These three pr
|
|
Harnessing stem cells and regenerative medicine to fight COVID-19
April 23, 2020
-
Researchers from The Ottawa Hospital and the University of Ottawa have been awarded $490,000 from the Stem Cell Network for two research projects that could help in the fight against COVID-19. These peer-reviewed grants are part of an overall investm
|
|
Researchers join the fight against COVID-19
April 2, 2020
-
As hospitals and communities band together to fight COVID-19, researchers at The Ottawa Hospital are harnessing their unique expertise and resources to help.
|
|
Stem cells may heal lungs of premature babies
March 4, 2020
-
Premature babies need extra oxygen and mechanical intervention to breathe but this can damage their lungs, causing a chronic lung disease. A stem cell treatment soon to be tested in clinical trials at The Ottawa Hospital may help heal the lungs of pr
|
|
Could umbilical cord cell therapy help premature babies? Dr. Bernard Thébaud awarded $638,000 from Stem Cell Network for clinical trial
March 2, 2020
-
Dr. Bernard Thébaud and colleagues received $638,000 from the Stem Cell Network with in-kind matching funds from MDTB Cells GmbH to conduct a phase 1 clinical trial of umbilical cord cell therapy for premature babies.
|
|
Cell therapy for premature babies: new lab study suggests wider treatment window may be possible
February 19, 2020
-
Bronchopulmonary dysplasia (BPD) is a chronic lung disease caused by the breathing equipment that keeps premature babies alive.
|
|
Acute kidney injury and chronic kidney disease— newfound hope for treatment
September 12, 2019
-
Researchers at The Ottawa Hospital are working together to help prevent and treat acute kidney injury and chronic kidney disease.
|
|
The promise of CAR-T therapy for cancer: meta-analysis shows the big picture
August 14, 2019
-
CAR-T therapy, which uses a patient’s own genetically modified immune cells, is one of the most exciting advances in cancer treatment. To get a big picture view of the field, Drs. Manoj Lalu and Dean Fergusson led a team that analyzed data from nearl
|
|
Autologous hematopoietic stem cell transplantation recommended as a standard of care for certain kinds of MS in the U.S.
March 13, 2019
-
The American Society for Blood and Marrow Transplantation has recommended that stem cell transplantation for MS, which has been pioneered at The Ottawa Hospital, be considered a “standard of care, clinical evidence available” for people with certain
|
|
Patients and clinical trial experts key to upcoming made-in-Canada CAR-T clinical trial
March 1, 2019
-
Researchers at The Ottawa Hospital and the University of Ottawa are known around the world for their expertise in designing and leading clinical trials, and they're now applying this knowledge to create a made-in-Canada approach for CAR-T cell cl
|
|
Using stem cells to treat brain cancer: pilot study highlights potential new approach
August 16, 2018
-
Stem cells are usually associated with repairing damaged tissue and treating degenerative diseases, but they also have a unique property that may be harnessed to fight cancer. When injected into the body, stem cells naturally migrate to tumours, and
|
|
Experimental stem cell therapy tested for rare lung disease
April 30, 2018
-
A Canadian-led research team has launched a clinical trial of an experimental stem cell therapy for pulmonary arterial hypertension. This rare and deadly disease occurs when the arteries that supply blood to the lungs become so damaged that blood can
|
|
Could stem cells repair the heart, fight infections, mend premature lungs, and heal the brain after stroke?
April 11, 2018
-
Ottawa researchers closer to finding out, thanks to $999,900 from the Stem Cell Network
Researchers from The Ottawa Hospital, CHEO and the University of Ottawa are bringing discoveries made in the lab closer to human trials and therapies, thanks
|
|
Pre-treated cells boost blood vessel repair
November 29, 2017
-
Endothelial colony-forming cells (ECFCs) are stem-like cells found in umbilical cord blood that help repair damaged blood vessels. They may hold promise for the treatment of stroke, heart attack and blocked leg arteries. However, their rate of bloo
|
|
Stem cells for septic shock: world-first trial establishes safety, sets stage for larger trial
November 2, 2017
-
Stem cells are usually thought of as the building blocks of the body – able to give rise to all our cells and organs. But Dr. Lauralyn McIntyre, Dr. Duncan Stewart, Dr. Dean Fergusson and their colleagues are testing the idea that certain stem cells
|
|
Ottawa scientist wins Canada's top stem cell prize for multiple sclerosis trial
September 6, 2017
-
Dr. Harold Atkins, stem cell transplant physician and scientist at The Ottawa Hospital and the University of Ottawa, will receive the prestigious Till & McCulloch Award for “exceptional contributions to global stem cell research.” The award will
|
|
Ottawa researchers to play lead role in new cancer immunotherapy studies
February 15, 2017
-
BioCanRx funds research into CAR-T and virus-infected cell therapy
Researchers from The Ottawa Hospital and the University of Ottawa will play a lead role in cutting-edge research on cancer immunotherapy, thanks to five new peer-reviewed researc
|